Tekmira Studying Up for the Big 21 Test

TKMR is another biotechnology stock worth keeping on the long radar if we continue to see the sector in general keep melting higher. 

This one has Ebola exposure, which enabled it to enjoy a few pops in 2014 during that Ebola run-up.

But fundamental or news-related reasons aside, the stock is still sporting a very bullish buy volume pattern, seen on the bottom pane of the zoomed-out daily chart, below.

If the stock can surge over $21, the 50-day moving average just above current price, I would expect a nice move into next week. 

With biotechs like ESPR FOLD KITE JUNO showing signs of a sector perhaps wanting to go full-on parabolic, it makes sense to add TKMR to the list of other names we have highlighted, such as BLUE ONCE RARE.